Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2011 - 2025)
Lineage Cell Therapeutics (LCTX) reported Other Operating Expenses of $66000.0 for Q4 2025, down 57.14% on a YoY basis from $154000.0 in Q4 2024, and up 1220.0% quarter-over-quarter from $5000.0 in Q3 2025.
Lineage Cell Therapeutics (LCTX) Other Operating Expenses (2011 - 2025) Analysis & Trends
Lineage Cell Therapeutics has reported Other Operating Expenses for 9 years, with the latest figure at $66000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses fell 57.14% year-over-year to $66000.0; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (up 5396.32% YoY), and the FY2025 full-year result was $15.0 million, up 4386.83% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $66000.0, up from $5000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $14.9 million in Q2 2025, with the low at $5000.0 in Q3 2025.
- Historically, Other Operating Expenses has averaged $1.4 million across 3 years, with a median of $98000.0 in 2024.
- The largest YoY upside for Other Operating Expenses was 33715.91% in 2025 against a maximum downside of 86.84% in 2025.
- Lineage Cell Therapeutics' Other Operating Expenses stood at $169000.0 in 2023, then declined by 8.88% to $154000.0 in 2024, then sank by 57.14% to $66000.0 in 2025.
- The last three Other Operating Expenses figures came in at $66000.0 (Q4 2025), $5000.0 (Q3 2025), and $14.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2018 | -108,000.00 |
| Mar 31, 2018 | 800,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2014 | 12,000.00 |
| Sep 30, 2014 | 43.47 Mn |
| Jun 30, 2014 | -9.51 Mn |
| Mar 31, 2014 | -8.10 Mn |
| Dec 31, 2013 | -68.33 Mn |
| Sep 30, 2013 | 67.47 Mn |